The participants were divided into four groups, including healthy postmenopausal women, postmenopausal women with osteoporosis, T2DM postmenopausal women treated with insulin once daily, and T2DM postmenopausal women treated with metformin (500 mg) twice daily. Here, INS is linked to osteoporosis.